Skip to contentB
Biomerica Inc
B
BMRABiomerica Inc Q2 2026 · 10-Q
Revenue$1.21M$1.21M−26.0% vs Q2 2025 Net Income-$1.32M-$1.32MN/M vs Q2 2025 EPS Diluted-$0.45-$0.45N/M vs Q2 2025 Gross Profit$51,000−88.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biomerica Inc · CIK 73290 · Engraved from SEC EDGAR
Operating Cash Flowderived-$991,000N/M Margins · derivedGross margin4.2%−22.5 pt vs Q2 2025
Operating margin-113.5%−52.8 pt vs Q2 2025
Net margin-109.1%−51.0 pt vs Q2 2025
ended Nov 30, 2025 · filed Jan 14, 2026 · 45 d after period end